Caenorhabditis elegans in high-throughput screens for anti-infective compounds
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Program in Innate Immunity, Department of Medicine, Division of Infectious Diseases and ImmunologyDocument Type
Journal ArticlePublication Date
2018-10-01
Metadata
Show full item recordAbstract
New classes of antimicrobials that are effective therapies for infections with multi-drug resistant pathogens are urgently needed. The nematode Caenorhabditis elegans has been incorporated into small molecule screening platforms to identify anti-infective compounds that provide protection of a host during infection. The use of a live animal in these screening systems offers several advantages, including the ability to identify molecules that boost innate immune responses in a manner advantageous to host survival and compounds that disrupt bacterial virulence mechanisms. In addition, new classes of antimicrobials that target the pathogen have been uncovered, as well as interesting chemical probes that can be used to dissect new mechanisms of host-pathogen interactions.Source
Peterson ND, Pukkila-Worley R. Caenorhabditis elegans in high-throughput screens for anti-infective compounds. Curr Opin Immunol. 2018 Oct;54:59-65. doi: 10.1016/j.coi.2018.06.003. Epub 2018 Jun 20. PMID: 29935375; PMCID: PMC6463281. Link to article on publisher's site
DOI
10.1016/j.coi.2018.06.003Permanent Link to this Item
http://hdl.handle.net/20.500.14038/35201PubMed ID
29935375Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.coi.2018.06.003